Teaching hospital Program year 2025 Source: CMS Open Payments

Prov Regl Med Center Everett

WA

CCN 500014 CMS hospital 17017

Open in the dashboard

General payments

$605,125

130 payments

Research payments

$10,618,064

836 payments

Through program year 2025, Prov Regl Med Center Everett is reported as receiving $605,125 in general payments and $10,618,064 in research payments from drug and medical device manufacturers.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

12 rows
Year Kind Amount Payments
2025 General $56,450 19
2025 Research $249,970 19
2024 General $59,500 20
2024 Research $478,993 74
2023 General $66,875 25
2023 Research $874,671 118
2022 General $147,306 38
2022 Research $1,223,512 179
2021 General $244,744 20
2021 Research $3,387,645 196
2020 General $30,250 8
2020 Research $4,403,274 250

Breakdown

Who paid General payments · program years 2020–2025
  1. Purdue Pharma L.P. $228,762 2 payments
  2. Genentech, Inc. $63,393 1 payment
  3. Gilead Sciences, Inc. $35,900 13 payments
  4. Boehringer Ingelheim Pharmaceuticals, Inc. $34,250 12 payments
  5. AstraZeneca Pharmaceuticals LP $33,400 16 payments
  6. AbbVie, Inc. $28,875 12 payments
  7. E.R. Squibb & Sons, L.L.C. $18,000 6 payments
  8. Pfizer Inc. $15,500 6 payments
  9. Sanofi Pasteur Inc. $14,000 5 payments
  10. Stryker Corporation $13,531 7 payments
  11. Other $119,515 50 payments
What the payments were for General payments · program years 2020–2025
  1. Space rental or facility fees (teaching hospital only) $263,175 102 payments
  2. Grant $245,512 10 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $74,893 5 payments
  4. Debt forgiveness $12,638 1 payment
  5. Education $6,030 3 payments
  6. Gift $1,862 2 payments
  7. Long term medical supply or device loan $892 6 payments
  8. Honoraria $123 1 payment
Products named General payments · program years 2020–2025
  1. Mavyret $20,000 8 payments
  2. Lokelma $14,650 9 payments
  3. Andexxa $13,750 5 payments
  4. Camzyos $12,000 4 payments
  5. Zerbaxa $11,500 4 payments
  6. Biktarvy $9,000 3 payments
  7. Recarbrio $8,500 3 payments
  8. Dificid $8,500 3 payments
  9. Leqvio $8,000 3 payments
  10. Entresto $8,000 3 payments
  11. Other $149,907 73 payments

A payment can name more than one product, so these amounts overlap.

130 general · 836 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

A teaching hospital's total is institutional. It is money reported as going to the hospital itself, and it is kept separate from anything reported about the individual clinicians who work there — the two are never added together.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record